These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 37773572)
21. Soluble PD-L1 as an early marker of progressive disease on nivolumab. Mahoney KM; Ross-Macdonald P; Yuan L; Song L; Veras E; Wind-Rotolo M; McDermott DF; Stephen Hodi F; Choueiri TK; Freeman GJ J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35131863 [TBL] [Abstract][Full Text] [Related]
22. [Programmed cell death protein 1 and its ligands regulate immune balance in allergic rhinitis]. Wen SL; Li F; Zhao F; Zuo JJ; Deng YQ; Zhang W; Tao ZZ Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Apr; 55(4):384-390. PubMed ID: 32306637 [No Abstract] [Full Text] [Related]
23. [Novel miRNAs as Potential Regulators of PD-1/PD-L1 Immune Checkpoint, and Prognostic Value of MIR9-1 and MIR124-2 Methylation in Ovarian Cancer]. Kushlinskii NE; Loginov VI; Utkin DO; Filippova EA; Burdennyy AM; Korotkova EA; Pronina IV; Lukina SS; Smirnova AV; Gershtein ES; Braga EA Mol Biol (Mosk); 2020; 54(6):990-996. PubMed ID: 33276362 [TBL] [Abstract][Full Text] [Related]
24. PD-1/PD-L1 pathway activation restores the imbalance of Th1/Th2 and treg/Th17 cells subtypes in immune thrombocytopenic purpura patients. Wu D; Liu Y; Pang N; Sun M; Wang X; Haridia Y; Zhao F; Qin Y; Fan W; Guo X; Ding J Medicine (Baltimore); 2019 Oct; 98(43):e17608. PubMed ID: 31651870 [TBL] [Abstract][Full Text] [Related]
25. Correlation between PD-1 and sPD-L1 expression levels in peripheral blood of DLBCL patients and their clinicopathological characteristics. Wang L; Cao C; Qiu J; Zhang J; He Q; Song L; Xie L; Ma J Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):44-50. PubMed ID: 38430041 [TBL] [Abstract][Full Text] [Related]
26. Soluble PD-L1 in blood correlates positively with neutrophil and negatively with lymphocyte mRNA markers and implies adverse sepsis outcome. Derigs M; Heers H; Lingelbach S; Hofmann R; Hänze J Immunol Res; 2022 Oct; 70(5):698-707. PubMed ID: 35732880 [TBL] [Abstract][Full Text] [Related]
27. Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis. Scirocchi F; Strigari L; Di Filippo A; Napoletano C; Pace A; Rahimi H; Botticelli A; Rughetti A; Nuti M; Zizzari IG Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430974 [TBL] [Abstract][Full Text] [Related]
28. Clinical significance of soluble programmed cell death-1 and soluble programmed cell death-ligand 1 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Tominaga T; Akiyoshi T; Yamamoto N; Taguchi S; Mori S; Nagasaki T; Fukunaga Y; Ueno M PLoS One; 2019; 14(2):e0212978. PubMed ID: 30807610 [TBL] [Abstract][Full Text] [Related]
29. [Expression of soluble programmed death-1, soluble programmed death ligand 1 proteins and immune status in patients with oral lichen planus]. Luo L; Shu M; Li S; Cai Y Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Oct; 50(10):585-9. PubMed ID: 26757624 [TBL] [Abstract][Full Text] [Related]
30. [Significance of soluble PD-L1 in patients with chronic hepatitis B and hepatitis C]. Ke RM; Ouyang LJ; Li WF; Peng XM Zhonghua Gan Zang Bing Za Zhi; 2023 Feb; 31(2):133-137. PubMed ID: 37137827 [No Abstract] [Full Text] [Related]
31. Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer. Niu M; Liu Y; Yi M; Jiao D; Wu K Front Immunol; 2022; 13():827921. PubMed ID: 35386715 [TBL] [Abstract][Full Text] [Related]
33. The interaction between the soluble programmed death ligand-1 (sPD-L1) and PD-1 Li X; Du H; Zhan S; Liu W; Wang Z; Lan J; PuYang L; Wan Y; Qu Q; Wang S; Yang Y; Wang Q; Xie F Front Immunol; 2022; 13():830606. PubMed ID: 35935985 [TBL] [Abstract][Full Text] [Related]
34. Immune checkpoint activity exacerbate renal interstitial fibrosis progression by enhancing PD-L1 expression in renal tubular epithelial cells. Zhang Y; Mi X; Zhang Y; Li J; Qin Y; He P; Zhao Y; Su B; He L Transl Res; 2024 Sep; 271():52-67. PubMed ID: 38723861 [TBL] [Abstract][Full Text] [Related]
35. Soluble PD-L1 and B7-H4 serum levels during the course of physiological pregnancy. Mach P; Köninger A; Reisch B; Kimmig R; Gellhaus A Am J Reprod Immunol; 2022 Mar; 87(3):e13519. PubMed ID: 34974633 [TBL] [Abstract][Full Text] [Related]
36. Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma. Han X; Gu YK; Li SL; Chen H; Chen MS; Cai QQ; Deng HX; Zuo MX; Huang JH J Cancer Res Clin Oncol; 2019 Feb; 145(2):303-312. PubMed ID: 30267213 [TBL] [Abstract][Full Text] [Related]
37. Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma. Vilain RE; Menzies AM; Wilmott JS; Kakavand H; Madore J; Guminski A; Liniker E; Kong BY; Cooper AJ; Howle JR; Saw RPM; Jakrot V; Lo S; Thompson JF; Carlino MS; Kefford RF; Long GV; Scolyer RA Clin Cancer Res; 2017 Sep; 23(17):5024-5033. PubMed ID: 28512174 [No Abstract] [Full Text] [Related]
38. Rescuing Cancer Immunity by Plasma Exchange in Metastatic Melanoma (ReCIPE-M1): protocol for a single-institution, open-label safety trial of plasma exchange to clear sPD-L1 for immunotherapy. Davidson TM; Foster N; Lucien F; Markovic S; Dong H; Winters JL; Park SS; Orme JJ BMJ Open; 2022 May; 12(5):e050112. PubMed ID: 35551087 [TBL] [Abstract][Full Text] [Related]
39. Soluble PD-L1 with PD-1-binding capacity exists in the plasma of patients with non-small cell lung cancer. Takeuchi M; Doi T; Obayashi K; Hirai A; Yoneda K; Tanaka F; Iwai Y Immunol Lett; 2018 Apr; 196():155-160. PubMed ID: 29366663 [TBL] [Abstract][Full Text] [Related]
40. Secretion of human soluble programmed cell death protein 1 by chimeric antigen receptor-modified T cells enhances anti-tumor efficacy. Zhang A; Sun Y; Wang S; Du J; Gao X; Yuan Y; Zhao L; Yang Y; Xu L; Lei Y; Duan L; Xu C; Ma L; Wang J; Hu G; Chen H; Wang Q; Hu L; Zhang B Cytotherapy; 2020 Dec; 22(12):734-743. PubMed ID: 32684339 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]